Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
Holmes, F A
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. [electronic resource] - Journal of the National Cancer Institute Dec 1991 - 1797-805 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
0027-8874
10.1093/jnci/83.24.1797-a doi
Adult
Aged
Agranulocytosis--chemically induced
Alkaloids--adverse effects
Antineoplastic Agents, Phytogenic--adverse effects
Breast Neoplasms--drug therapy
Doxorubicin--therapeutic use
Drug Evaluation
Female
Heart Diseases--chemically induced
Humans
Methotrexate--therapeutic use
Middle Aged
Muscular Diseases--chemically induced
Paclitaxel
Pain--chemically induced
Peripheral Nervous System Diseases--chemically induced
Remission Induction
Soft Tissue Neoplasms--drug therapy
Thrombocytopenia--chemically induced
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. [electronic resource] - Journal of the National Cancer Institute Dec 1991 - 1797-805 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
0027-8874
10.1093/jnci/83.24.1797-a doi
Adult
Aged
Agranulocytosis--chemically induced
Alkaloids--adverse effects
Antineoplastic Agents, Phytogenic--adverse effects
Breast Neoplasms--drug therapy
Doxorubicin--therapeutic use
Drug Evaluation
Female
Heart Diseases--chemically induced
Humans
Methotrexate--therapeutic use
Middle Aged
Muscular Diseases--chemically induced
Paclitaxel
Pain--chemically induced
Peripheral Nervous System Diseases--chemically induced
Remission Induction
Soft Tissue Neoplasms--drug therapy
Thrombocytopenia--chemically induced